Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$2,778,210
+$310,630 QoQ
Shares Held
5,593
+1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#599
of 1,742 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SIGNATUREFD, LLC holds $13,806,120 across 160 Biotechnology names. VRTX ranks #1 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,593 | $2,778,210 | |
| 2 | ARGX |
Argenx SE
|
2,075 | $1,925,122 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,756 | $1,094,936 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,063 | $621,024 | |
| 5 | INCY |
Incyte Corp
|
4,178 | $473,618 | |
| 6 | GMAB |
Genmab A/S
|
16,442 | $451,661 | |
| 7 | EXEL |
Exelixis, Inc.
|
7,184 | $390,881 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
6,510 | $378,426 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,778,210 | 5,593 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,467,580 | 5,526 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,405,074 | 5,305 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,998,538 | 5,103 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,359,560 | 5,300 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,765,898 | 5,705 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,033,232 | 5,049 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $2,394,696 | 5,149 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,387,659 | 5,094 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,208,764 | 5,284 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,992,133 | 4,896 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,546,747 | 4,448 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,456,907 | 4,140 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $1,182,772 | 3,754 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,005,531 | 3,482 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $971,985 | 3,357 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $836,634 | 2,969 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $688,177 | 2,637 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $506,617 | 2,307 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $304,009 | 1,676 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $667,798 | 3,312 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $711,071 | 3,309 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $719,655 | 3,045 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $544,512 | 2,001 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $591,361 | 2,037 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $390,000 | 1,639 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||